BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.60K | 26.50K | 36.60K | 52.20K | 89.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.60K | 26.50K | 36.60K | 52.20K | 89.00K |
| Cost of Revenue | 1.70K | 14.80K | 18.70K | 29.10K | 36.10K |
| Gross Profit | 6.00K | 11.90K | 18.20K | 23.50K | 53.30K |
| SG&A Expenses | 3.61M | 3.47M | 2.95M | 2.83M | 2.88M |
| Depreciation & Amortization | 33.10K | 26.80K | 26.80K | 26.80K | 26.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.13M | 4.85M | 4.16M | 3.75M | 3.83M |
| Operating Income | -5.12M | -4.82M | -4.12M | -3.70M | -3.74M |
| Income Before Tax | -5.21M | -4.95M | -4.31M | -4.00M | -3.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.21 | -4.95 | -4.31 | -4.00 | -3.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 106.00K | 43.50K | 19.00K | 3.40K | 3.60K |
| Net Income | -5.11M | -4.91M | -4.29M | -3.99M | -3.77M |
| EBIT | -5.12M | -4.82M | -4.12M | -3.70M | -3.74M |
| EBITDA | -5.09M | -4.79M | -4.10M | -3.67M | -3.71M |
| EPS Basic | -0.50 | -0.52 | -0.48 | -0.46 | -0.45 |
| Normalized Basic EPS | -0.30 | -0.31 | -0.30 | -0.29 | -0.28 |
| EPS Diluted | -0.50 | -0.52 | -0.49 | -0.47 | -0.45 |
| Normalized Diluted EPS | -0.30 | -0.31 | -0.30 | -0.29 | -0.28 |
| Average Basic Shares Outstanding | 41.84M | 37.75M | 35.38M | 34.38M | 33.37M |
| Average Diluted Shares Outstanding | 41.84M | 37.75M | 35.38M | 34.38M | 33.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |